ESTRO 2024 - Abstract Book

S957

Clinical - CNS

ESTRO 2024

The outcome of adults with intracranial grade 3 ependymoma depends on the location of the tumour, type of the resection and total dose applied. The irradiation on craniospinal axis did not result in better survival or time to local or distant progression.

Keywords: intracranial tumours, ependymoma grade 3

2947

Digital Poster

Gliosarcoma – Clinical outcomes and prognostic factors – An international multi-institutional analysis

Siyer Roohani 1,2,3 , Maximilian Mirwald 1 , Felix Ehret 1,4 , Jana Käthe Striefler 5 , Noelle Samira Jacob 5 , Enrico Pozzo 6 , Alessandra Gonnelli 7 , Camilla Satragno 8 , Ilinca Popp 9,10 , Johannes Steffel 9 , Jolina Handtke 11 , Soleiman Fabris Roohani 11 , Noa Marie Claßen 11 , Titus Rotermund 11 , Daniel Zips 11,4 , Peter Vajkoczy 12 , Ulrich Schüller 13,14,15 , Mateusz Jacek Spałek 16 1 Charité - Universitätsmedizin Berlin, Radiation Oncology, Berlin, Germany. 2 Berlin Institute of Health at Charité− Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin, Germany. 3 Charité − Universitätsmedizin Berlin, Berlin, Germany, German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. 4 Charité - Universitätsmedizin Berlin, German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. 5 University Medical Center Hamburg-Eppendorf, Department of Internal Medicine II, Oncology/Hematology/BMT/Pneumology, Hamburg, Germany. 6 Istituto Oncologico Veneto IOV-IRCCS, Department of Radiotherapy, Padua, Italy. 7 Azienda Ospedaliero Universitaria Pisana, Radiation Oncology Unit, Pisa, Italy. 8 University of Genoa, Department of Experimental Medicine, Genoa, Italy. 9 Medical Center-University of Freiburg, Department of Radiation Oncology, Freiburg, Germany. 10 German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany. 11 Charité - Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany. 12 Charité - Universitätsmedizin Berlin, Department of Neurosurgery, Berlin, Germany. 13 University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, Germany. 14 University Medical Center Hamburg-Eppendorf, Research Institute Children's Cancer Center Hamburg, Hamburg, Germany. 15 University Medical Center Hamburg-Eppendorf, Institute of Neuropathology, Hamburg, Germany. 16 Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland

Purpose/Objective:

This study sought to describe oncological outcomes and investigate prognostic factors for patients with gliosarcoma (GSM).

Material/Methods: